AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 281 min read

Lie Sean sold $25.1M of CBRS

Lie Sean (Chief Technology Officer) sold 120,000 shares of Cerebras Systems Inc. (CBRS) at an average of $208.97 ($204.50–$212.14, $25.08M total) across 9 trades on 2026-09-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lie Sean
Published Sep 28, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 2:45 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$CBRS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The disclosed sale adds supply pressure on CRSR shares and may influence short‑term sentiment.

02

Market read

A $25M insider sell by the CTO is a material event that could affect CRSR's short‑term price dynamics.

03

What to watch

The 10b5-1 plan may have been set before recent news, reducing informational value.

Relevance 6/10Novelty 7/10Timing: post‑market filing

Background

Form 4 filings provide the first public disclosure of insider transactions, offering fresh data for traders.

Market effects

Sector

May raise questions about Cerebras' growth outlook within the AI hardware sector.

Regional

Limited to U.S. tech investors; no broader regional effect.

Global

Minimal global impact beyond sector peers.

Counterpoint

What could challenge this read

The sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • company
    Cerebras Systems Inc.

    AI hardware manufacturer listed on NASDAQ (CRSR).

  • person
    Lie Sean

    Chief Technology Officer of Cerebras, insider seller.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CBRS insider trading history →

Related articles

OCT 6
$CBRSMed

Cerebras stock jumps 9%; Q3 sales guide sets a harder test

Cerebras Systems (CBRS) stock rose 9% after OpenAI's Sam Altman reaffirmed their partnership. The company's Q3 revenue guidance suggests 2.4% sequential growth. OpenAI committed to 750MW of capacity, with an option for 1.25GW. Cerebras reported $56.8M in OpenAI-related revenue in Q2, 31.5% of total GAAP revenue. The stock remains below its IPO price of $185.

techi.com2 min
OCT 5
$CBRSHigh

CBRS Stock Surges Over 6% in Monday Pre-Market: What's the Sam Altman Connection? - Cerebras Systems (NAS

Cerebras Systems (CBRS) shares rose 6.56% premarket after OpenAI CEO Sam Altman called it a 'close partner,' easing concerns. Analysts noted strong ties with OpenAI, despite Nvidia (NVDA) running its new model. Barclays' Tom O'Malley called the sell-off 'overdone,' while Paul Meeks upgraded CBRS to Buy with a $209 target, citing high AI demand. CBRS is down 52.45% YTD.

benzinga.com2 min
OCT 5
$CBRSMed

Mizuho reiterates Cerebras Systems stock rating on inference growth

Mizuho reiterated its Outperform rating and $300 price target for Cerebras Systems (CBRS), citing growth in fast inference workloads. The firm projects a $550B market by 2030, with CBRS trading near its 52-week low at $166.43. CBRS reported 91% revenue growth over the last year, and analysts have revised earnings upwards, though some suggest overvaluation. The company unveiled the CS-4 system, with improved performance and compute density, expected in Q3.

investing.com2 min